Multidisciplinary Team Management of Patients with Hepatocellular Carcinoma

Global Burden of Disease Cancer C, Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, et al. The global burden of cancer 2013. JAMA oncology. 2015;1(4):505–27.

Ryerson AB, Eheman CR, Altekruse SF, Ward JW, Jemal A, Sherman RL, et al. Annual report to the nation on the status of cancer, 1975-2012, featuring the increasing incidence of liver cancer. Cancer. 2016;122(9):1312–37.

Wright FC, De Vito C, Langer B, Hunter A. Expert panel on multidisciplinary cancer conference S. Multidisciplinary cancer conferences: a systematic review and development of practice standards. Eur J Cancer. 2007;43(6):1002–10.

Fennell ML, Das IP, Clauser S, Petrelli N, Salner A. The organization of multidisciplinary care teams: modeling internal and external influences on cancer care quality. J Natl Cancer Inst Monogr. 2010;2010(40):72–80.

Warnecke R, Fennell M, Havlicek P. Network demonstration projects and cancer control: the head and neck demonstration networks. Prog Clin Biol Res. 1983;120:247–65.

Kane R. Organizing to improve the management of a disease: an overview of the breast-cancer networks. Prog Clin Biol Res. 1983;120:211–30.

Clauser SB, Johnson MR, O’Brien DM, Beveridge JM, Fennell ML, Kaluzny AD. Improving clinical research and cancer care delivery in community settings: evaluating the NCI community cancer centers program. Implementation science : IS. 2009;4:63.

King M, Jones L, McCarthy O, Rogers M, Richardson A, Williams R, et al. Development and pilot evaluation of a complex intervention to improve experienced continuity of care in patients with cancer. Br J Cancer. 2009;100(2):274–80.

Zapka JG, Taplin SH, Solberg LI, Manos MM. A framework for improving the quality of cancer care: the case of breast and cervical cancer screening. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2003;12(1):4–13.

• Davila JA, Kramer JR, Duan Z, Richardson PA, Tyson GL, Sada YH, et al. Referral and receipt of treatment for hepatocellular carcinoma in United States veterans: effect of patient and nonpatient factors. Hepatology. 2013;57(5):1858–68. This important manuscript outlines the most important factors associated with the receipt of care in a VA population outlying the heterogeneity of care and the complex nature of providing good cancer care.

Chirikov VV, Mullins CD, Hanna N, Breunig IM, Seal B, Shaya FT. Multispecialist care and mortality in hepatocellular carcinoma. Am J Clin Oncol. 2015;38(6):557–63.

Lemieux-Charles L, McGuire WL. What do we know about health care team effectiveness? A review of the literature. Medical care research and review : MCRR. 2006;63(3):263–300.

Alexander JA, Lichtenstein R, Jinnett K, Wells R, Zazzali J, Liu D. Cross-functional team processes and patient functional improvement. Health Serv Res. 2005;40(5 Pt 1):1335–55.

Shortell SM, Marsteller JA, Lin M, Pearson ML, Wu SY, Mendel P, et al. The role of perceived team effectiveness in improving chronic illness care. Med Care. 2004;42(11):1040–8.

• Cohen GS, Black M. Multidisciplinary management of hepatocellular carcinoma: a model for therapy. J Multidiscip Healthc. 2013;6:189–95. An excellent overview on the multitude of treatment strategies utilized in a newly diagnosed patient with HCC and how these treatments are best decided in a multidisciplinary format.

• Yopp AC, Mansour JC, Beg MS, Arenas J, Trimmer C, Reddick M, et al. Establishment of a multidisciplinary hepatocellular carcinoma clinic is associated with improved clinical outcome. Ann Surg Oncol. 2014;21(4):1287–95. This manuscript details a stage stratified benefit in overall survival upon the establishment of a multidiscliplinary HCC clinic.

Mokdad A, Browning T, Mansour JC, Zhu H, Singal AG, Yopp AC. Implementation of a voice messaging system is associated with improved time-to-treatment and overall survival in patients with hepatocellular carcinoma. J Natl Compr Cancer Netw. 2016;14(1):38–46.

Tan D, Yopp A, Beg MS, Gopal P, Singal AG. Meta-analysis: underutilization and disparities of treatment among patients with hepatocellular carcinoma in the United States. Aliment Pharmacol Ther. 2013;38(7):703–12.

Singal AG, Waljee AK, Patel N, Chen EY, Tiro JA, Marrero JA, Yopp AC. Therapeutic delays lead to worse survival among patients with hepatocellular carcinoma. J Natl Compr Canc Netwk. 2013;11(9):1101–8.

Gashin L, Tapper E, Babalola A, Lai KC, Miksad R, Malik R, et al. Determinants and outcomes of adherence to recommendations from a multidisciplinary tumour conference for hepatocellular carcinoma. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2014;16(11):1009–15.

Zhang J, Mavros MN, Cosgrove D, Hirose K, Herman JM, Smallwood-Massey S, et al. Impact of a single-day multidisciplinary clinic on the management of patients with liver tumours. Curr Oncol. 2013;20(2):e123–31.

Chang TT, Sawhney R, Monto A, Davoren JB, Kirkland JG, Stewart L, et al. Implementation of a multidisciplinary treatment team for hepatocellular cancer at a veterans affairs medical Center improves survival. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2008;10(6):405–11.